ki:elements

Validation of speech as a measurement for depressive symptoms

Screening for preclinical signs of depression in healthy young volunteers based on free speech.

In collaboration with:

Prof. Dr. Julia Karbach

PD Dr. Jessica Peter

Dr. Caroline Kuhn

Share this article

Discover more articles

Validation ki:e SB-C

We are grateful to announce that we will soon be collaborating in a major new decentralized trial, funded by the Alzheimer Drug Discoveries Foundation (ADDF)

Read

ki:e SB-C

Today, clinical research on early Alzheimer’s Disease (AD) dementia relies on invasive procedures and extended cognitive examinations both for screening and within trial usage. With

Read

Listen to Alzheimer

Alzheimer’s disease (AD) affects speech and language (Cummings, Benson, Hill & Read, 1985). This can be caused by the disease affecting language as a neurocognitive

Read